To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Can Objective Measurement… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Can Objective Measurements Improve Treatment Outcomes in Parkinson’s Disease?

Magazine article
Authors Filip Bergquist
Malcolm Horne
Published in European Neurological Review
Volume 9
Issue 1
Pages 27-30
ISSN 1758-3837
Publication year 2014
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 27-30
Language en
Keywords Parkinson's disease, bradykinesia, dyskinesia, fluctuations, measurement, treatment, scales, accelerometry, outcomes, compliance
Subject categories Clinical Medicine, Neurology


Many examples in medicine show that therapies are most effective when measurement is used to guide their implementation, dose and effects. There are effective symptomatic therapies for the motor symptoms of Parkinson’s disease, which improve quality of life and have a health economic justification for their subsidisation. As measurement should lead to more effective deployment of these therapies, even in a percentage of cases, then costs of therapy would be reduced and by that percentage. We conclude that there is a clear need for continuous objective measures of dyskinesia and bradykinesia while patients go about their normal daily activities. The benefit of measurement would be greatest if these measures were directed at treating fluctuations.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?